Related Experiment Video
Updated: May 9, 2026

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Identification of disease-related spatial covariance patterns using neuroimaging data
Phoebe Spetsieris1, Yilong Ma, Shichun Peng
1Center for Neurosciences, The Feinstein Institute for Medical Research.
Journal of Visualized Experiments : Jove
|July 16, 2013
Summary
The scaled subprofile model (SSM) identifies brain network variations in patient and control groups. This method aids in diagnosing diseases like Parkinson's by creating characteristic covariance patterns.
Area of Science:
- Neuroimaging analysis
- Multivariate statistics
- Biomarker discovery
Background:
- The scaled subprofile model (SSM) is a multivariate principal component analysis (PCA)-based algorithm.
- It identifies major sources of variation in patient and control group brain image data.
- It reduces complex group image sets into significant covariance patterns and subject scores.
Purpose of the Study:
- To apply the SSM methodology to FDG PET data from Parkinson's Disease (PD) patients and healthy controls.
- To derive a characteristic covariance pattern biomarker for PD.
- To demonstrate the utility of SSM in disease-related pattern identification and diagnosis.
Main Methods:
- Applied SSM to voxel-by-voxel covariance data of steady-state multimodality images.
- Used logarithmic conversion and mean centering to remove global mean effects.
- Employed logistic regression analysis of subject scores to derive disease-related spatial covariance patterns.
- Validated patterns using bootstrap resampling and prospective datasets.
Main Results:
- The SSM successfully reduced complex brain image data into a few significant, linearly independent covariance patterns (group invariant subprofiles, GIS).
- Subject scores derived from these patterns correlated with clinical descriptors.
- A characteristic covariance pattern biomarker for Parkinson's Disease was successfully derived using FDG PET data.
Conclusions:
- The SSM is an effective tool for identifying and characterizing disease-related brain network alterations.
- Derived disease-related patterns can be used for differential diagnosis and assessing disease progression.
- The study successfully demonstrated the application of SSM for PD biomarker discovery using FDG PET imaging.

